Sign in
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Journal article   Open access  Peer reviewed

Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma

Michael A Gillette, Shankha Satpathy, Song Cao, Saravana M Dhanasekaran, Suhas V Vasaikar, Karsten Krug, Francesca Petralia, Yize Li, Wen-Wei Liang, Boris Reva, …
Cell, Vol.182(1), pp.200-225.e35
2020-07-09
PMID: 32649874

Abstract

Lung Neoplasms - genetics Lung Neoplasms - drug therapy Humans Middle Aged Carcinogenesis - genetics Male DNA Copy Number Variations - genetics DNA Methylation - genetics Mutation - genetics Phosphoproteins - metabolism Carcinogenesis - pathology Lung Neoplasms - immunology Oncogene Proteins, Fusion Phenotype Adenocarcinoma of Lung - genetics Proteogenomics Adenocarcinoma of Lung - drug therapy Aged, 80 and over Biomarkers, Tumor - metabolism Adult Female Aged Adenocarcinoma of Lung - immunology Proteome - metabolism
url
https://doi.org/10.1016/j.cell.2020.06.013View
Published (Version of record) Open

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Highly Cited Paper 
Collaboration types
Domestic collaboration
International collaboration
Citation topics
2 Chemistry
2.211 Mass Spectrometry
2.211.497 Proteomics
Web Of Science research areas
Biochemistry & Molecular Biology
Cell Biology
ESI research areas
Molecular Biology & Genetics

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details